ACM
SANA icon

Aquatic Capital Management’s Sana Biotechnology SANA Stock Holding History

Aquatic Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,500
Closed -$10.4K – 1577
2024
Q3 		$10.4K Buy
+2,500
New +$13.1K ﹤0.01% 1084
2023
Q1 		– Sell
-10,500
Closed -$40K – 1693
2022
Q4 		$40K Buy
+10,500
New +$51.3K ﹤0.01% 1048

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Aquatic Capital Management's SANA Position: Q4 2024 in Review

Aquatic Capital Management sold out of Sana Biotechnology (SANA) in Q4 2024, closing a stake of 2,500 shares — an estimated $10.4K sold.

Aquatic Capital Management first reported a position in SANA in Q4 2022 and held it in 2 quarters. The position peaked at $40K in Q4 2022. 164 funds tracked by Wall St. Rank hold SANA as of Q4 2024.

  • Aquatic Capital Management reported no remaining Sana Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Aquatic Capital Management sold 2,500 Sana Biotechnology shares in Q4 2024, an estimated $10.4K.
  • Aquatic Capital Management first reported a position in Sana Biotechnology in Q4 2022 and held it in 2 quarters.
  • Aquatic Capital Management's Sana Biotechnology position peaked at $40K in Q4 2022.
  • 164 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2024.

Based on Aquatic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.